DK116726B - Fremgangsmåde til opspaltning af racemisk α-hydroxy-β,β-dimethyl-γ-butyrolacton i de optisk aktive antipoder. - Google Patents

Fremgangsmåde til opspaltning af racemisk α-hydroxy-β,β-dimethyl-γ-butyrolacton i de optisk aktive antipoder.

Info

Publication number
DK116726B
DK116726B DK207866AA DK207866A DK116726B DK 116726 B DK116726 B DK 116726B DK 207866A A DK207866A A DK 207866AA DK 207866 A DK207866 A DK 207866A DK 116726 B DK116726 B DK 116726B
Authority
DK
Denmark
Prior art keywords
butyrolactone
racemic
cleavage
hydroxy
dimethyl
Prior art date
Application number
DK207866AA
Other languages
Danish (da)
English (en)
Inventor
Hoffmann La Roche & Co Ag F
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK116726B publication Critical patent/DK116726B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK207866AA 1965-04-23 1966-04-22 Fremgangsmåde til opspaltning af racemisk α-hydroxy-β,β-dimethyl-γ-butyrolacton i de optisk aktive antipoder. DK116726B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH570365A CH468997A (de) 1965-04-23 1965-04-23 Verfahren zur Aufspaltung eines racemischen Gemisches in die optischen Antipoden

Publications (1)

Publication Number Publication Date
DK116726B true DK116726B (da) 1970-02-09

Family

ID=4297967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207866AA DK116726B (da) 1965-04-23 1966-04-22 Fremgangsmåde til opspaltning af racemisk α-hydroxy-β,β-dimethyl-γ-butyrolacton i de optisk aktive antipoder.

Country Status (9)

Country Link
BE (1) BE679805A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6678826D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH468997A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1568755A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK116726B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES325859A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1083076A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL153540B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU77366A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809179A1 (de) * 1978-03-03 1979-09-13 Basf Ag Verfahren zur extraktion von pantolacton aus seinen waessrigen loesungen
US4225506A (en) * 1978-05-30 1980-09-30 Hoffmann-La Roche Inc. Process for manufacturing a diketone
CN111499602B (zh) * 2020-05-14 2022-06-07 安徽泰格生物科技有限公司 一种钙盐法提取dl-泛解酸内酯拆分液中d-泛解酸内酯的方法
CN112457181B (zh) * 2020-12-11 2023-08-29 黄冈美丰化工科技有限公司 一种d-泛酸钙的合成方法

Also Published As

Publication number Publication date
CH468997A (de) 1969-02-28
BR6678826D0 (pt) 1973-09-18
NL153540B (nl) 1977-06-15
DE1568755A1 (de) 1970-03-05
YU77366A (en) 1978-02-28
GB1083076A (en) 1967-09-13
NL6605421A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-10-24
ES325859A1 (es) 1967-07-01
BE679805A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-10-21

Similar Documents

Publication Publication Date Title
DK127415B (da) Fremgangsmåde til fremstilling af α-benzyl-β,β-dialkoxypropionitriler.
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
DK125255B (da) Fremgangsmåde til fremstilling af lipase.
DK108757C (da) Fremgangsmåde til fremstilling af transparente, linære polyamider.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK134673B (da) Fremgangsmåde til spaltning af racemisk tetramisol.
DK116726B (da) Fremgangsmåde til opspaltning af racemisk α-hydroxy-β,β-dimethyl-γ-butyrolacton i de optisk aktive antipoder.
DK138222B (da) Fremgangsmåde til fremstilling af optisk aktiv trans-chrysantheminsyre ved spaltning af d,1-trans-chrysantheminsyre ved hjælp af en optisk aktiv base.
DK120709B (da) Analogifremgangsmåde til fremstilling af substituerede hydroxyfenyl-alkylaminer eller optisk aktive antipoder eller salte deraf.
DK132499B (da) Fremgangsmåde til opspaltning af racemisk tetramisol.
DK138650B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner.
DK133428B (da) Fremgangsmåde til fremstilling af optisk aktive organiske forbindelser, specielt secosteroider.
DK122760B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider.
DK139384B (da) Fremgangsmåde til spaltning af dl-allethrolon i de optisk aktive antipoder.
DK118651B (da) Fremgangsmåde til fremstilling af extracellulære enzymer.
DK128279B (da) Fremgangsmåde til fremstilling af α,ω-alkylendiaminer.
DK115106B (da) Fremgangsmåde til rensning af 2,2,2-trifluor-1-klor-1-bromætan.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK131502B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktiv alfa-ureidobenzylpenicillin eller salte deraf.
DK112606B (da) Fremgangsmåde til rensning af insulin.
DK127059B (da) Analogifremgangsmåde til fremstilling af substituerede 1-phenoxy-2-hydroxy-3-tert.butylaminopropaner eller salte heraf eller de tilsvarende optisk aktive antipoder.
DK116594B (da) Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner.
DK121513B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-substituerede noratropiniumsalte.
DK114962B (da) Fremgangsmåde til fremstilling af α, α, α', α'-tetramethyl-xylylen-dicarbinoler.
DK112871B (da) Fremgangsmåde til fremstilling af optisk-aktivt 13β-propyl-18,19-bis-nor-progesteron.